Apexigen Statistics
Share Statistics
Apexigen has n/a
shares outstanding. The number of shares has increased by null%
in one year.
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
| 410 |
| 6.98% |
Short Selling Information
| n/a |
| n/a |
| n/a |
| n/a |
Valuation Ratios
The PE ratio is -0.43 and the forward
PE ratio is null.
Apexigen's PEG ratio is
-0.01.
| -0.43 |
| n/a |
| 0 |
| n/a |
| 2.12 |
| -0.44 |
| -0.01 |
Financial Ratio History Enterprise Valuation
Apexigen has an Enterprise Value (EV) of -1.2M.
| 0 |
| 0.04 |
| 0.04 |
| 0.04 |
Financial Position
The company has a current ratio of 1.29,
with a Debt / Equity ratio of 0.02.
| 1.29 |
| 1.29 |
| 0.02 |
| n/a |
| n/a |
| 52.98 |
Financial Efficiency
Return on Equity is -493.21% and Return on Invested Capital is -494.48%.
| -493.21% |
| -137.62% |
| -494.48% |
| n/a |
| n/a |
| undefined |
| 0 |
| n/a |
Taxes
| -617K |
| 1.92% |
Stock Price Statistics
The stock price has increased by 14.81% in the
last 52 weeks. The beta is 0, so Apexigen's
price volatility has been lower than the market average.
| 0 |
| 14.81% |
| 0.03 |
| 0.06 |
| 52.55 |
| 5,877 |
Income Statement
| n/a |
| n/a |
| -32.69M |
| -31.45M |
| -32.58M |
| n/a |
| -1.59 |
Full Income Statement Balance Sheet
The company has 14.8M in cash and 106K in
debt, giving a net cash position of 14.7M.
| 14.8M |
| 106K |
| 14.7M |
| -176.79M |
| n/a |
| n/a |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -30.69M
and capital expenditures -57K, giving a free cash flow of -30.75M.
| -30.69M |
| -57K |
| -30.75M |
| -1.55 |
Full Cash Flow Statement Margins
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |